Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism

Abstract

Homozygous Arg-16 patients are susceptible to clinically important increases in asthma exacerbations during chronic dosing with the short acting beta(2) agonist salbutamol.